ENDOZIME AW TRIPLE PLUS is a unique formulation of protease, amylase, lipase, carbohydrase and proprietary enzymes with A.P.A. (Advanced Proteolytic Action) which removes all bio-burden and inhibits rust. A.P.A. is the latest enzymatic breakthrough developed by Ruhof Healthcare that greatly increases protein enzyme activity to provide a faster more thorough penetration into hard-to-reach places on surgical instruments and scopes.
Cleaning and Disinfection, Ruhof
Endozime® AW Triple Plus with APA
ENDOZIME AW TRIPLE PLUS is a unique formulation of protease, amylase, lipase, carbohydrase and proprietary enzymes with A.P.A. (Advanced Proteolytic Action) which removes all bio-burden and inhibits rust. A.P.A. is the latest enzymatic breakthrough developed by Ruhof Healthcare that greatly increases protein enzyme activity to provide a faster more thorough penetration into hard-to-reach places on surgical instruments and scopes.
Related products
-
PharmAssure® Pharmacy Filtration Devices HP4642
Read moreComplete range of filtration devices for the pharmacy setting Filters and venting devices assist in preparation and delivery of pharmaceutical products Wide selection of pore sizes for removal of microorganisms and hazardous particles Safe and effective vial venting to protect health care personnel from exposure to harmful drug aerosols
-
Pall AquaSafe™ AQ31F1SA
Read morePall-Aquasafe™ Disposable Water Filter – Tap For Up to 31 Day Use (with Jet Outlet)
-
3M™ Ioban™
Read moreDesigned with continuous broad-spectrum antimicrobial activity in the drape adhesive where it can’t be washed away Clinically shown to help reduce the risk of wound contamination and immobilize bacteria on the skin
-
3M™ Cavilon™
Read moreVersatile Solution that Guards Skin From the Outside in- solution for many skin problems including, medical adhesive-related skin injury (MARSI), periwound skin damage, peristomal skin damage, incontinence-associated dermatitis and other moisture and friction skin damage prevention needs
Reviews
There are no reviews yet.